Research output per year
Research output per year
Fingerprint
Dive into the research topics where Gernot Fugger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues
Olgiati, P., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Zanardi, R., Fugger, G., Ferri, R., Tripodi, M., Baune, B. T., Fabbri, C., Mendlewicz, J. & Serretti, A., 15 Jan 2025, In: Journal of Affective Disorders. 369, p. 1021-1030 10 p.Research output: Journal article (peer-reviewed) › Journal article
2 Citations (Scopus) -
The clinical perspective on late-onset depression in European real-world treatment settings
Bartova, L., Fugger, G., Dold, M., Kautzky, A., Bairhuber, I., Kloimstein, P., Fanelli, G., Zanardi, R., Weidenauer, A., Rujescu, D., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., Fabbri, C., Serretti, A. & Kasper, S., Jul 2024, In: European Neuropsychopharmacology. 84, p. 59-68 10 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access2 Citations (Scopus) -
Esketamin-Behandlung im akut-tagesklinischen Setting: Kasuistischer Beitrag zur wirksamen multidisziplinären Behandlung der therapieresistenten Depression
Stefan, R. & Fugger, G., 01 Sept 2023, In: psychopraxis. neuropraxis. 26, 4, p. 218-221Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Bartova, L., Fugger, G., Dold, M., Kautzky, A., Fanelli, G., Zanardi, R., Albani, D., Weidenauer, A., Rujescu, D., Souery, D., Mendlewic, J., Montgomery, S., Zohar, J., Fabbri, C., Serretti, A. & Kasper, S., 01 Jul 2023, In: Journal of Affective Disorders. 332, p. 105-114 10 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access2 Citations (Scopus) -
Silexan for treatment of anxiety and depression in the context of COVID-19
Bartova, L., Dold, M., Fugger, G., Weidenauer, A., Rujescu, D. & Kasper, S., May 2023, In: European Neuropsychopharmacology. 70, p. 47-48 2 p.Research output: Journal article (peer-reviewed) › Letter/short communication
Open Access5 Citations (Scopus)